Timothy H J Goodship researcher
Goodship, Timothy H.J.
VIAF ID: 33751600 (Personal)
Permalink: http://viaf.org/viaf/33751600
Preferred Forms
- 100 1 _ ‡a Goodship, Timothy H. J.
- 100 1 _ ‡a Goodship, Timothy H. J.
-
-
- 100 0 _ ‡a Timothy H J Goodship ‡c researcher
Works
Title | Sources |
---|---|
Hypophosphatemic effect of 1% amino acid dialysis solution | |
Immune complex glomerulonephritis, myasthenia gravis and compensated hypothyroidism in a patient following allogeneic bone marrow transplantation | |
The influence of nutritional status on complications after operations for lung cancer | |
Insulin-mediated changes in PD and glucose uptake after correction of acidosis in humans with CRF. | |
Is complement factor H a susceptibility factor for IgA nephropathy? | |
Is decreased treatment time in hemodialysis patients harmful if solute clearance is maintained? | |
Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for disease heterogeneity | |
Long-term follow-up of patients presenting to adult nephrologists with chronic pyelonephritis and 'normal' renal function | |
Membrane cofactor protein and factor I: mutations and transplantation | |
Meningococcal B Vaccine Failure With a Penicillin-Resistant Strain in a Young Adult on Long-Term Eculizumab | |
Mitochondrial Haplogroup and the Risk of Acute Kidney Injury Following Cardiac Bypass Surgery | |
Monogenic diabetes, renal dysplasia and hypopituitarism: a patient with a HNF1A mutation | |
Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort | |
Mutations in TBX18 Cause Dominant Urinary Tract Malformations via Transcriptional Dysregulation of Ureter Development | |
A non-synonymous polymorphism | |
A novel method for direct measurement of complement convertases activity in human serum. | |
Nutritional approaches to preserving renal function | |
Nutritional screening in patients on hemodialysis: is subjective global assessment an appropriate tool? | |
Osmoregulation of thirst and vasopressin release in severe chronic renal failure. | |
Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation. | |
Pre and interdialytic acid-base balance in hemodialysis patients. | |
Production of interleukin 1 receptor antagonist and interleukin 1 during haemodialysis with cellulose membranes | |
Psychiatric side-effects of acyclovir in patients with chronic renal failure | |
Recovery of 13C in breath from infused NaH13CO3 increases during euglycaemic hyperinsulinaemia | |
Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor | |
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype | |
The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies | |
The role of complement in C3 glomerulopathy | |
Self-assessment colour review of renal medicine, c1997: | |
Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation | |
Short-term studies on the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis | |
Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoracotomy | |
Sodium bicarbonate treatment and ubiquitin gene expression in acidotic human subjects with chronic renal failure. | |
Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1beta mutations | |
Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T. | |
Telomere shortening and haemodialysis | |
Thrombotic Microangiopathy as a Cause of Chronic Kidney Transplant Dysfunction: Case Report Demonstrating Successful Treatment with Eculizumab | |
Thrombotic Microangiopathy in Inverted Formin 2-Mediated Renal Disease | |
Total-body potassium in insulin-dependent diabetes mellitus | |
Unimpaired Clearance of Somatostatin-14 in Chronic Renal Failure | |
An unusual case of haemolytic uraemic syndrome following endoscopic retrograde cholangiopancreatography rapidly improved with eculizumab | |
Update on evaluating complement in hemolytic uremic syndrome | |
Urinary tract effects of HPSE2 mutations | |
Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum | |
Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum? | |
Use of the complement inhibitor Coversin to treat HSCT-associated TMA | |
Wegener's granulomatosis: an unusual presentation | |
What have isotope studies in humans told us about the nutritional effects of acidosis in dialysis? | |
What is the relationship between metabolic acidosis and nutritional status in dialysis patients? | |
Where next with atypical hemolytic uremic syndrome? | |
Whole body leucine turnover and nutritional status in continuous ambulatory peritoneal dialysis | |
Whole-genome linkage and association scan in primary, nonsyndromic vesicoureteric reflux | |
Withdrawal of renal replacement therapy in Newcastle upon Tyne: 1964-1993. |